Business Description
Opthea Ltd
NAICS : 325412
SIC : 2834
ISIN : US17254C1009
Share Class Description:
OPT: ADRCompare
Compare
Traded in other countries / regions
OPT.AustraliaOPT.USAUKJ.Germany IPO Date
2011-06-07Description
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1209.59 | |||||
| Equity-to-Asset | -0.28 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -6.91 | |||||
| Beneish M-Score | -3.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -68.8 | |||||
| 3-Year EPS without NRI Growth Rate | -99.3 | |||||
| 3-Year FCF Growth Rate | -133.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.97 | |||||
| 9-Day RSI | 56.05 | |||||
| 14-Day RSI | 53.52 | |||||
| 6-1 Month Momentum % | 126.01 | |||||
| 12-1 Month Momentum % | -2.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | |||||
| Quick Ratio | 5.1 | |||||
| Cash Ratio | 4.82 | |||||
| Days Sales Outstanding | 2059.94 | |||||
| Days Payable | 30349.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -20.2 | |||||
| Shareholder Yield % | -17.69 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -100 | |||||
| Operating Margin % | -141465.52 | |||||
| Net Margin % | -138608.62 | |||||
| FCF Margin % | -59298.29 | |||||
| ROE % | -14841.78 | |||||
| ROA % | -115.96 | |||||
| ROIC % | -8237.16 | |||||
| ROC (Joel Greenblatt) % | -75995.02 | |||||
| ROCE % | -125.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.95 | |||||
| EV-to-EBITDA | -0.95 | |||||
| EV-to-Revenue | 1218.8 | |||||
| EV-to-Forward-Revenue | 11.53 | |||||
| EV-to-FCF | -2.05 | |||||
| Earnings Yield (Greenblatt) % | -105.26 | |||||
| FCF Yield % | -23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Opthea Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.117 | ||
| EPS (TTM) ($) | -2.406 | ||
| Beta | 1.46 | ||
| Volatility % | 87.3 | ||
| 14-Day RSI | 53.52 | ||
| 14-Day ATR ($) | 0.258242 | ||
| 20-Day SMA ($) | 3.426055 | ||
| 12-1 Month Momentum % | -2.01 | ||
| 52-Week Range ($) | 1.6 - 4.4 | ||
| Shares Outstanding (Mil) | 82.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Opthea Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Opthea Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Opthea Ltd Frequently Asked Questions
What is Opthea Ltd(OPT)'s stock price today?
The current price of OPT is $3.62. The 52 week high of OPT is $4.40 and 52 week low is $1.60.
When is next earnings date of Opthea Ltd(OPT)?
The next earnings date of Opthea Ltd(OPT) is 2024-08-30 Est..
Does Opthea Ltd(OPT) pay dividends? If so, how much?
Opthea Ltd(OPT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers